Methyl arachidonyl fluorophosphonate inhibits Mycobacterium tuberculosis thioesterase TesA and globally affects vancomycin susceptibility.

MLA

Yang, Dong, et al. “Methyl Arachidonyl Fluorophosphonate Inhibits Mycobacterium Tuberculosis Thioesterase TesA and Globally Affects Vancomycin Susceptibility.” FEBS Letters, vol. 594, no. 1, Jan. 2020, pp. 79–93. EBSCOhost, https://doi.org/10.1002/1873-3468.13555.

APA

Yang, D., Vandenbussche, G., Vertommen, D., Evrard, D., Abskharon, R., Cavalier, J., Berger, G., Canaan, S., Khan, M. S., Zeng, S., Wohlkönig, A., Prévost, M., Soumillion, P., & Fontaine, V. (2020). Methyl arachidonyl fluorophosphonate inhibits Mycobacterium tuberculosis thioesterase TesA and globally affects vancomycin susceptibility. FEBS Letters, 594(1), 79–93. https://doi.org/10.1002/1873-3468.13555

Chicago

Yang, Dong, Guy Vandenbussche, Didier Vertommen, Damien Evrard, Romany Abskharon, Jean‐François Cavalier, Gilles Berger, et al. 2020. “Methyl Arachidonyl Fluorophosphonate Inhibits Mycobacterium Tuberculosis Thioesterase TesA and Globally Affects Vancomycin Susceptibility.” FEBS Letters 594 (1): 79–93. doi:10.1002/1873-3468.13555.